Navigation Links
American Imaging Management to Partner with Blue Cross of Idaho
Date:1/29/2009

CHICAGO, Jan. 29 /PRNewswire/ -- American Imaging Management (AIM), an operating subsidiary of WellPoint, Inc. (NYSE: WLP), and leading imaging benefit management and technology company with health plan clients representing over 30 million consumers, announced that it has reached an agreement to provide diagnostic imaging management services for Blue Cross of Idaho.

Under this agreement, AIM will administer Blue Cross of Idaho's radiology benefit management program to enhance the appropriate use of advanced diagnostic imaging procedures delivered in an outpatient, non-emergent setting.

"Blue Cross of Idaho looks forward to working with AIM to promote the appropriate use of diagnostic imaging," said Scott French, M.D., senior medical director, Blue Cross of Idaho. "AIM's focus on clinical and service excellence will benefit our members and providers."

"Diagnostic imaging continues to be one of the fastest growing areas of cost and utilization in health care," said Brandon Cady, president of AIM. "AIM appreciates the opportunity to work with Blue Cross of Idaho to help ensure that consumers today are receiving the quality tests they need while creating greater efficiency in the delivery of health care. We look forward to working with Blue Cross of Idaho to promote clinical excellence, and to provide outstanding service to providers and leading web-based tools."

AIM is a leader in providing innovative solutions for managing advanced imaging services. AIM pioneered the integration of technology and clinical content for advanced imaging management through the introduction of web-based services in 2002. AIM also introduced the first set of web-enabled tools to promote quality and cost transparency into the selection of some of the highest value diagnostic imaging facilities. Most recently, the company launched a new line of services to manage outpatient cardiac service delivery.

About American Imaging Management

American Imaging Management, Inc. ("AIM") is a leading company in the radiology benefit management industry. AIM promotes the appropriate use of diagnostic imaging through the application of widely accepted clinical guidelines delivered through an innovative platform of technologies and programs. AIM pioneered the use of web technology in diagnostic imaging management and has continually integrated service and technology to create a more effective and efficient clinical review process to support the physician-patient relationship. Through a commitment to delivering excellence in clinical content, service, innovation and operational performance, AIM has developed a national client base of health plans, and currently provides management services to over 30 million health plan members. AIM is an operating subsidiary of WellPoint, Inc. (NYSE: WLP). For more information on AIM, please visit http://www.americanimaging.net.


'/>"/>
SOURCE American Imaging Management, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Many Older Americans Have Active Sex Lives
2. Despite grumbling, most Americans say they are happy at work
3. Record Number of Americans Lack Health Insurance
4. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
5. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
6. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
7. Novo Nordisk Appoints New Leader of North American Business
8. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
9. Primary biliary cirrhosis more severe in African-American and Hispanic patients
10. AOA President Calls on Congress to Reauthorize SCHIP and Take Action to Ensure Health Care Coverage for All Americans
11. American Chemical Societys Weekly Presspac -- Sept. 5, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... ... overview on laser diffraction analysis as a tool to characterize particle size distributions ... potential to obtain improved results and novel scientific findings. It describes methods of ...
(Date:2/27/2017)... , ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. ... has disclosed that despite scientific studies, the Center for Disease Control ( CDC ) ... disease . Kenneth B. Liegner, M.D. has compiled into a single volume a ...
(Date:2/27/2017)... BC (PRWEB) , ... February 27, 2017 , ... ... drug rehabilitation and alcohol treatment programs in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ ... to its team. The new hire, Mackenzie Alsager, showcases the Centre's commitment to ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... ... San Francisco and environs, is proud to announce an upgrade to the company's ... the upgraded Yelp page on topics as diverse as Platelet Rich Plasma (PRP) ...
(Date:2/26/2017)... ... February 25, 2017 , ... The February 13, 2017, assassination of Kim ... over nerve agents and the deadly use of chemical weapons. Many questions exist about ... even small doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan Neurosurgical ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... , Feb. 27, 2017  A ... P. Vallely , MBBS, PhD, FRACS, of  Sydney ... University of Sydney will be published in ... of the American College of Cardiology ... beating heart bypass surgery technique (anOPCABG) reduced ...
(Date:2/27/2017)... Biophysics Corporation, a global medical device manufacturer based in ... growth in 2016 when compared to the previous year based ... fueled by its AffloVest® sales in the United ... global sales of surgical product lines. Said H. ... 25 th year in delivering high-quality, innovative medical devices ...
(Date:2/27/2017)... ROCKVILLE, Md. , Feb. 27, 2017 /PRNewswire/ ... "RegeneRx"), a clinical-stage drug development company focused on ... its licensee for RGN-137, GtreeBNT Co., Ltd., received ... its Phase 3 clinical trial design for RGN-137 ... dermal wound healing gel that incorporates Thymosin beta ...
Breaking Medicine Technology: